Colonic transcriptional profiling in resistance and susceptibility to trichuriasis: Phenotyping a chronic colitis and lessons for iatrogenic helminthosis

Inflammatory Bowel Diseases

Volumn 16, Issue 12, 2010, Pages 2065-2079

  Levison, S E ^a   McLaughlin, J T ^a   Zeef, L A H ^a   Fisher, P ^a   Grencis, R K ^a   Pennock, J L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

colitis; gene expression; helminth; phenotype; susceptibility

Indexed keywords

ANIMAL MODEL; APOPTOSIS; ARTICLE; CHEMOTAXIS; CLUSTER ANALYSIS; COLITIS; DIARRHEA; DISEASE PREDISPOSITION; DISEASE RESISTANCE; DNA MICROARRAY; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MAPPING; GENETIC TRANSCRIPTION; HELMINTHIASIS; HELPER CELL; HISTOLOGY; HOMEOSTASIS; IATROGENIC DISEASE; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RETROVIRUS INFECTION; TH1 CELL; TH17 CELL; TRICHURIASIS; UPREGULATION; WEIGHT REDUCTION;

EID: 78649627708     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21326     Document Type: Article

References (61)

1. Bouma G, Strober W,. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003; 3: 521-533.
2. Xavier RJ, Podolsky DK,. Unraveling the pathogenesis of inflammatory bowel disease. Nature. 2007; 448: 427-434.
3. Logan RF,. Inflammatory bowel disease incidence: up, down or unchanged? Gut. 1998 42: 309-311.
4. Loftus EV,. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence and environmental influences. Gastroenterology. 2004; 126: 1504-1517.
5. Braus NA, Elliott DE,. Advances in the pathogenesis and treatment of IBD. Clin Immunol. 2009; 132: 1-9.
6. Yazdanbakhsh M, Kremsner PG, van Ree R,. Allergy, parasites and the hygiene hypothesis. Science. 2002; 296: 490-494.
7. Maizels RM, Yazdanbakhsh M,. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol. 2003; 3: 733-744.
8. Summers RW, Elliott DE, Qadir K, et al. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol. 2003; 98: 2034-2040.
9. Summers R, Elliott D, Urban J, et al. Trichuris suis therapy in Crohn's disease. Gut. 2005; 54: 87-90.
10. Summers R, Elliott D, Urban J, et al. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology. 2005; 128: 825-832.
11. Kradin RL, Badizadegan K, Auluck P, et al. Iatrogenic Trichuris suis infection in a patient with Crohn's disease. Arch Pathol Lab Med. 2006; 130: 718-720.
12. Else KJ, Finkelman FD, Malizewski CR, et al. Cytokine mediated regulation of chronic intestinal helminth infection. J Exp Med. 1994; 179: 347-351.
13. Cliffe LJ, Grencis RK,. The Trichuris muris system: a paradigm of resistance and susceptibility to intestinal nematode infection. Adv Immunol. 2004; 57: 255-307.
14. Bancroft AJ, McKenzie AN, Grencis RK,. A critical role for IL-13 in resistance to intestinal nematode infection. J Immunol. 1998; 160: 3463-3461.
15. Bancroft AJ, Artis D, Donaldson DD, et al. Gastrointestinal nematode expulsion in IL-4 knockout mice is IL-13 dependent. Eur J Immunol. 2000; 30: 2083-2091.
16. Else KJ, Grencis RK,. Cellular responses to the murine nematode parasite Trichuris muris. Differential cytokine production during acute or chronic infection. Immunology. 1991; 72: 508-513.
17. Grencis RK,. Cytokine regulation of resistance and susceptibility to intestinal nematode infection - from host to parasite. Vet Parasitol. 2001; 100: 45-50.
18. Williams-Blangero S, McGarvey ST, Subedi J, et al. Genetic component to susceptibility to Trichuris trichiura: evidence from two Asian populations. Genet Epidemiol. 2002; 22: 254-264.
19. Jackson JA, Turner JD, Rentoul L, et al. T-helper cell type 2 responsiveness predicts future susceptibility to gastrointestinal nematodes in humans. J Infect Dis. 2004: 190; 1804-1811.
20. Wakelin D,. Acquired immunity to Trichuris muris in the albino laboratory mouse. Parasitology. 1967; 57: 515-524.
21. Else KJ, Entwistle GM, Grencis RK,. Correlation between worm burden and markers of Th1 and Th2 cell subset induction in an inbred strain of mouse infected with Trichuris muris. Parasite Immunol. 1993; 15: 595-600.
22. Quackenbush J,. Computational analysis of microarray data. Nat Rev Genet. 2001; 2: 418-427.
23. Storey JD, Tibshirani R,. Statistical significance for genome-wide studies. Proc Natl Acad Sci U S A. 2003; 100: 9440-9445.
24. Huang DW, Sherman BT, Lempicki RA,. Systemic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4: 44-57.
25. Fisher P, Hedeler C, Wolstencroft K, et al. A systematic strategy for large-scale analysis of genotype-phenotype correlations: identification of candidate genes involved in African trypanosomiasis. Nucleic Acids Res. 2007; 35: 5625-5633.
26. Murthy SN, Cooper HS, Shim H, et al. Treatment of dextran sulphate sodium induced murine colitis by intracolonic cyclosporine. Dig Dis Sci. 1993; 38: 1722-1734.
27. Lees CW, Zacharias WJ, Tremelling M, et al. Analysis of germline Gli1 variation implicates Hedgehog signaling in the regulation of intestinal inflammatory pathways. PLoS Med. 2008; 5: 1761-1775.
28. Uchino R,. Domain analysis of the Runx1 transcription factor responsible for modulating T-cell receptor-Î/CD4 and interlukin-4/interferon-γ expression in CD4+ peripheral T lymphocytes. Immunology. 2009: 128: 16-24.
29. te Velde AA, de Kort F, Sterrenburg, et al. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease. Inflamm Bowel Dis. 2007; 13: 325-330.
30. Hansen JJ, Holt L, Sartor RB,. Gene expression patterns in experimental colitis in IL-10-deficient mice. Inflamm Bowel Dis. 2009; 15: 890-899.
31. Wolf AM, Wolf D, Rumpold H, et al. Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin Immunol. 2004; 113: 47-55.
32. Carlson M, Raab Y, Seveus L, et al. Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut. 2002; 50: 501-506.
33. Foell D, Wittkowski H, Ren Z, et al. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J Pathol. 2008; 216: 183-192.
34. Hardin JA, Wallace LE, Wong JFK, et al. Aquaporin expression is downregulated in a murine model of colitis and in patients with ulcerative colitis, Crohn's disease and infectious colitis. Cell Tissue Res. 2004; 318: 313-323.
35. Lawrance IC, Fiocchi C, Chakravarti S,. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet. 2001; 10: 445-456.
36. Strober W, Fuss IJ, Blumberg RS,. The immunology of mucosal models of inflammation. Annu Rev Immunol. 2002; 20: 495-549.
37. Datta R, deSchoolmeester ML, Hedler C, et al. Identification of novel genes in intestinal tissue that are regulated after infection with an intestinal nematode parasite. Infect Immun. 2005; 73: 4025-4033.
38. Cliffe LJ, Humphreys NE, Lane TE, et al. Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion. Science. 2005; 308: 1463-1465.
39. Kristensen NN, Olsen J, Gad M, et al. Genome wide expression profiling during protection from colitis by regulatory T cells. Inflamm Bowel Dis. 2008; 14: 75-86.
40. Papadakis KA, Prehn J, Zhu D, et al. Expression and regulation of the chemokine receptor CXCR3 on lymphocytes from normal and inflammatory bowel disease mucosa. Inflamm Bowel Dis. 2004; 10: 778-788.
41. Singh UP, Singh S, Iqbal N, et al. IFN-gamma-inducible Chemokines enhance adaptive immunity and colitis. J Interferon Cytokine Res. 2003; 23: 591-600.
42. Lehrke M, Konrad A, Schachinger V, et al. CXCL16 is a surrogate marker of inflammatory bowel disease. Scand J Gastroenterol. 2008; 43: 283-288.
43. + regulatory T-cells. Inflamm Bowel Dis. 2006; 12: 612-618.
44. Reinecker HC, Loh EY, Ringler DJ, et al. Monocyte-chemoattractant protein1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology. 1995; 108: 40-50.
45. Rezaie A, Parker RD, Abdollahi M,. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci. 2007; 52: 2015-2021.
46. Langmann T, Moehle C, Mauerer R, et al. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane-x-receptor target genes. Gastroenterology. 2004; 127: 26-40.
47. Noble CL, Addas AR, Cornelius J, et al. Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut. 2008; 57: 1398-1405.
48. Peltekova VD, Wintle RF, Rubin LA, et al. Functional variants of CTN cation transporter genes are associated with Crohn's disease. Nat Genet. 2004; 35: 471-475.
49. Waller S, Tremelling M, Bredin F, et al. Evidence for association of OCTN genes and IBD5 with ulcerative colitis. Gut. 2006; 55: 809-814.
50. Wojtal KA, Eloranta JJ, Hruz, et al. Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients. Drug Metab Dispos. 2009; 37: 1871-1877.
51. Ho GT, Soranzo N, Nimmo ER, et al. ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach. Hum Mol Genet. 2006; 15: 797-805.
52. Zeissig S, Burgel N, Gunzel D, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut. 2007; 56: 61-72.
53. Prasad S, Mingrino R, Kaukinen K, et al. Inflammatory processes have differential effects on claudins 2, 3, and 4 in colonic epithelial cells. Lab Invest. 2005; 85: 1139-1162.
54. Wirtz S, Neurath MF,. Mouse models of inflammatory bowel disease. Adv Drug Del Rev. 2007; 59: 1073-1083.
55. Mizoguchi A, Mizoguchi E,. Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol. 2008; 43: 1-17.
56. Warren S, Sommers SC,. Pathogenesis of ulcerative colitis. Am J Pathol. 1949; 25: 657-679.
57. Peyrin-Biroulet L, Chamaillard M, Gonzalez F, et al. Mesenteric fat in Crohn's disease: a pathogenic hallmark or an innocent bystander? Gut. 2007; 56: 577-583.
58. Little MC, Bell LV, Cliffe LJ, Else KJ,. The characterization of intraepithelial lymphocytes, and isolated lymphoid follicles in the large intestine of mice infected with the intestinal nematode parasite Trichuris muris. J Immunol. 2005; 175: 6713-6722.
59. Levison DA, Reid A, Burt AD, et al. The gastrointestinal system. In: Muir's textbook of pathology, 14th ed. London: Hodder Arnold; 2008: 221-259.
60. 2. Eur J Gastroenterol Hepatol. 2008; 20: 555-560.
61. Williams-Blangero S, VandeBerg JL, Subedi J, et al. Two quantitative trait loci influence whipworm (Trichuris trichiura) infection in a Nepalese population. J Infect Dis. 2008; 197: 1198-1203.